Combined tumor and immune signals from genomes or transcriptomes predict outcomes of checkpoint inhibition in melanoma-Reference-Cited by-全球学者库

Combined tumor and immune signals from genomes or transcriptomes predict outcomes of checkpoint inhibition in melanoma

Published:2022-02 Issue:2 Volume:3 Page:100500
ISSN:2666-3791
Container-title:Cell Reports Medicine
language:en
Short-container-title:Cell Reports Medicine

Author:

Freeman Samuel S.^ORCID,Sade-Feldman Moshe^ORCID,Kim Jaegil,Stewart Chip,Gonye Anna L.K.,Ravi Arvind,Arniella Monica B.^ORCID,Gushterova Irena^ORCID,LaSalle Thomas J.^ORCID,Blaum Emily M.^ORCID,Yizhak Keren,Frederick Dennie T.,Sharova Tatyana,Leshchiner Ignaty,Elagina Liudmila,Spiro Oliver G.,Livitz Dimitri^ORCID,Rosebrock Daniel,Aguet François,Carrot-Zhang Jian,Ha Gavin^ORCID,Lin Ziao^ORCID,Chen Jonathan H.,Barzily-Rokni Michal,Hammond Marc R.,Vitzthum von Eckstaedt Hans C.,Blackmon Shauna M.,Jiao Yunxin J.,Gabriel Stacey,Lawrence Donald P.,Duncan Lyn M.,Stemmer-Rachamimov Anat O.,Wargo Jennifer A.,Flaherty Keith T.,Sullivan Ryan J.^ORCID,Boland Genevieve M.,Meyerson Matthew,Getz Gad,Hacohen Nir

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference101 articles.

1. Genomic correlates of response to CTLA-4 blockade in metastatic melanoma;Van Allen;Science,2015

2. Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance;Roh;Sci. Transl. Med.,2017

3. Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma;Zaretsky;N. Engl. J. Med.,2016

4. Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab;Riaz;Cell,2017

5. Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma;Hugo;Cell,2016

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting patient outcomes after treatment with immune checkpoint blockade: A review of biomarkers derived from diverse data modalities;Cell Genomics;2024-01

2. Enzyme-mediated depletion of methylthioadenosine restores T cell function in MTAP-deficient tumors and reverses immunotherapy resistance;Cancer Cell;2023-10

3. The future of affordable cancer immunotherapy;Frontiers in Immunology;2023-09-06

4. The “Great Debate” at Immunotherapy Bridge 2022, Naples, November 30th–December 1st, 2022;Journal of Translational Medicine;2023-04-22

5. Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer;Nature Genetics;2023-04-06